BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1574029)

  • 21. The predictive value of serum thyroglobulin in the follow-up of differentiated thyroid cancer.
    Roelants V; Nayer PD; Bouckaert A; Beckers C
    Eur J Nucl Med; 1997 Jul; 24(7):722-7. PubMed ID: 9211756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Follow up of thyroglobulin levels in patients with surgically treated, highly differentiated thyroid cancer].
    Szántó J; Vincze B; Sinkovits I; Karika Z; Daubner K; Péter I; Kazatsay I; Eckhardt S
    Orv Hetil; 1989 Aug; 130(32):1695-9. PubMed ID: 2780041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three-week thyroxine withdrawal thyroglobulin stimulation screening test to detect low-risk residual/recurrent well-differentiated thyroid carcinoma.
    Golger A; Fridman TR; Eski S; Witterick IJ; Freeman JL; Walfish PG
    J Endocrinol Invest; 2003 Oct; 26(10):1023-31. PubMed ID: 14759077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.
    Lima N; Cavaliere H; Tomimori E; Knobel M; Medeiros-Neto G
    J Endocrinol Invest; 2002 Feb; 25(2):110-5. PubMed ID: 11929080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serum thyroglobulin estimation for follow-up of patients with thyroid carcinoma (author's transl)].
    Botsch H; Schulz E; Lochner B
    Dtsch Med Wochenschr; 1979 Jul; 104(30):1072-4. PubMed ID: 467254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does undetectable basal Tg measured with a highly sensitive assay in the absence of antibodies and combined with normal ultrasonography ensure the absence of disease in patients treated for thyroid carcinoma?
    Rosário PW; Mineiro Filho AF
    Arq Bras Endocrinol Metabol; 2012 Mar; 56(2):149-51. PubMed ID: 22584569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Importance of postoperative stimulated thyroglobulin level at the time of 131I ablation therapy for differentiated thyroid cancer.
    Hasbek Z; Turgut B; Kilicli F; Altuntas EE; Yucel B
    Asian Pac J Cancer Prev; 2014; 15(6):2523-7. PubMed ID: 24761858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thallium-201 scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum thyroglobulin determinations.
    Ramanna L; Waxman A; Braunstein G
    J Nucl Med; 1991 Mar; 32(3):441-6. PubMed ID: 2005453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
    Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
    J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An evaluation of the value of first thyroglobulin determination in the diagnostics of metastases immediately following differentiated thyroid carcinoma surgery.
    Makarewicz J; Adamczewski Z; Rutkowski A; Mikosiński S; Knapska-Kucharska M; Gonerska-Szadkowska A; Oszukowska L; Karwowska A; Lewiński A
    Endokrynol Pol; 2006; 57(4):370-3. PubMed ID: 17006838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thyroglobulin mRNA amplification in peripheral blood of patients with differentiated thyroid carcinoma: what does it really mean?].
    Coelho SM; Vaisman M; de Carvalho DP
    Arq Bras Endocrinol Metabol; 2006 Jun; 50(3):427-35. PubMed ID: 16936982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The significance of thyroglobulin determination in the follow-up of patients with papillary or follicular thyroid carcinoma].
    Hennemann G; Hennemann IP; Docter R; Krenning EP
    Ned Tijdschr Geneeskd; 1989 Mar; 133(10):491-3. PubMed ID: 2651932
    [No Abstract]   [Full Text] [Related]  

  • 33. Critical evaluation of serum thyroglobulin levels and I-131 scans in post-therapy patients with differentiated thyroid carcinoma: concise communication.
    Echenique RL; Kasi L; Haynie TP; Glenn HJ; Samaan NA; Hill CS
    J Nucl Med; 1982 Mar; 23(3):235-40. PubMed ID: 7062137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metastatic papillary thyroid carcinoma with normal serum thyroglobulin level.
    Miller JH; Marcus CS
    Clin Nucl Med; 1988 Sep; 13(9):652-3. PubMed ID: 3180613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative determination of serum thyroglobulin to identify patients with differentiated thyroid cancer who may present recurrence without increased thyroglobulin.
    Gibelli B; Tredici P; De Cicco C; Bodei L; Sandri MT; Renne G; Bruschini R; Tradati N
    Acta Otorhinolaryngol Ital; 2005 Apr; 25(2):94-9. PubMed ID: 16116831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of serum thyroglobulin in the pre-operative evaluation of follicular thyroid tumours.
    Hocevar M; Auersperg M
    Eur J Surg Oncol; 1998 Dec; 24(6):553-7. PubMed ID: 9870733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant human TSH changes the multidisciplinary approach to patients with differentiated thyroid carcinoma. Two-year experience.
    Giusti M; Zoccola R; Guazzini B; Molinari E; Valenti S; Villa G; Bertolazzi L; Minuto F
    Minerva Endocrinol; 2003 Sep; 28(3):191-203. PubMed ID: 14605601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer.
    Grünwald F; Menzel C; Fimmers R; Zamora PO; Biersack HJ
    J Nucl Med; 1996 Dec; 37(12):1962-4. PubMed ID: 8970514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma?
    Ronga G; Fiorentino A; Paserio E; Signore A; Todino V; Tummarello MA; Filesi M; Baschieri I
    J Nucl Med; 1990 Nov; 31(11):1766-71. PubMed ID: 2121913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
    de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.